상단으로
Seegene receives STOP TB Outstanding Partner Award
Nov 25, 2015
?
On November 25, the 2nd “STOP TB Partnership Korea Night” was held at FKI Tower in Seoul, Korea. Organized by the STOP-TB Partnership KOREA (STBK), the purpose of the event was for individuals from all levels of Korean society who have worked hard to eradicate tuberculosis to gather together in an effort to come up with new strategies for mutual cooperation with the goal of creating a “world without tuberculosis.”
The event included a presentation ceremony for the Outstanding Partner Award in recognition of partner corporations and organizations that made the most significant contributions to international activities in 2015. Seegene was a joint recipient of the award, together with the Seegene Medical Foundation, Hyundai Motor Chung Mong-Koo Foundation, and Janssen Korea. The award recognized the combined efforts of its three award winners in creating regular programs for international tuberculosis management (begun last September with the launch of a local tuberculosis eradication program in Ulaanbaatar, Mongolia).
As its contribution to the tuberculosis eradication program in Ulaanbaatar, carried out through Korea-Mongolia cooperation, Seegene provided molecular diagnostic equipment, equipped with the latest multiplex real-time PCR, and medication for tuberculosis to be used to help fight its spread among university students and poverty of Mongolia who are vulnerable to the disease. Seegene is also funding efforts to strengthen local capabilities to diagnose tuberculosis as well as the training of healthcare personnel. In particular, the diagnostic equipment provided by Seegene for this program is capable of conducting the simultaneous detection of Mycobacterium tuberculosis and 38 mutations associated with MDR-TB in a single test, thereby screening for tuberculosis pathogens and identifying multi-drug resistance all at the same time. The equipment also enables the diagnosis of tuberculosis in the early stages.
[STOP TB Partnership Korea]
Launched in December 2010, STOP TB Partnership Korea is composed of 43 partner organizations, including representatives of the Korean government, National Assembly, tuberculosis-related health organizations, and international cooperative bodies, companies, and civic groups. Its aim is to provide funding for the treatment of tuberculosis among vulnerable social groups that are overlooked by the central government’s management of the disease and support tuberculosis management in developing countries in order to strengthen international cooperation on global tuberculosis eradication. Currently made up of over 1,400 partner organizations in 27 countries, the STOP TB Partnership was expanded and transferred to the jurisdiction of the WHO by the UN in 2015. Its headquarters are located in Geneva, Switzerland
Datenschutz-Präferenz-Center
Unbedingt erforderliche Cookies
Immer aktiv
Diese Cookies sind zur Funktion der Website erforderlich und können in Ihren Systemen nicht deaktiviert werden. In der Regel werden diese Cookies nur als Reaktion auf von Ihnen getätigte Aktionen gesetzt, die einer Dienstanforderung entsprechen, wie etwa dem Festlegen Ihrer Datenschutzeinstellungen, dem Anmelden oder dem Ausfüllen von Formularen. Sie können Ihren Browser so einstellen, dass diese Cookies blockiert oder Sie über diese Cookies benachrichtigt werden. Einige Bereiche der Website funktionieren dann aber nicht.
Funktionale Cookies
Diese Cookies ermöglichen die Bereitstellung erweiterter Funktionalitäten und dienen der Personalisierung. Die Cookies werden insbesondere als Reaktion auf Ihre Aktionen gesetzt und hängen von Ihren konkreten Serviceanfragen (z. B. Einstellung der Sprache) ab.
Analyse- und Marketing Cookies
Wir setzen darüber hinaus auch Analyse- und Marketing-Cookies ein. Dabei handelt es sich um Cookies, die technisch nicht erforderlich sind. Wir setzen diese ein, um Ihr Verhalten auf unserer Website zu verstehen und unser Angebot zu verbessern.